Novel human p53 mutations that are toxic to yeast can enhance transactivation of specific promoters and reactivate tumor p53 mutants (Q43652223)

25 November 2017

title

Novel human p53 mutations that are toxic to yeast can enhance transactivation of specific promoters and reactivate tumor p53 mutants (English)

1 reference

25 November 2017

Inga A

1

1 reference

25 November 2017

Resnick MA

series ordinal

2

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 June 2001

1 reference

25 November 2017

1 reference

25 November 2017

volume

20

1 reference

25 November 2017

issue

26

1 reference

25 November 2017

page(s)

3409-3419

1 reference

Regulation of p53 stability

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204457

p53 mutants have selective dominant-negative effects on apoptosis but not growth arrest in human cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204457

Suppression of human colorectal carcinoma cell growth by wild-type p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204457

Human p53 inhibits growth in Schizosaccharomyces pombe

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204457

Dominant-negative p53 mutations selected in yeast hit cancer hot spots

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204457

Genetic selection of intragenic suppressor mutations that reverse the effect of common p53 cancer mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204457

Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204457

Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204457

Regulation of p53 downstream genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204457

Definition of a consensus binding site for p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204457

A simple p53 functional assay for screening cell lines, blood, and tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204457

Activation of c-myc gene expression by tumor-derived p53 mutants requires a discrete C-terminal domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204457

Use of transcription reporters with novel p53 binding sites to target tumour cells expressing endogenous or virally transduced p53 mutants with altered sequence-specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204457

p53-oriented cancer therapies: current progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204457

The complexity of p53 modulation: emerging patterns from divergent signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204457

Arrest of G(1)-S progression by the p53-inducible gene PC3 is Rb dependent and relies on the inhibition of cyclin D1 transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204457

14-3-3sigma is a p53-regulated inhibitor of G2/M progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204457

p53 mutants exhibiting enhanced transcriptional activation and altered promoter selectivity are revealed using a sensitive, yeast-based functional assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204457

Oncogenic forms of p53 inhibit p53-regulated gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204457

21 January 2018

p53: puzzle and paradigm

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204457

A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204457

Differential activation of target cellular promoters by p53 mutants with impaired apoptotic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204457

How p53 binds DNA as a tetramer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204457

Human p53 and CDC2Hs genes combine to inhibit the proliferation of Saccharomyces cerevisiae

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204457

p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204457

Reprimo, a new candidate mediator of the p53-mediated cell cycle arrest at the G2 phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204457

Regulation of the p53 tumor suppressor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204457

Identification of a novel class of genomic DNA-binding sites suggests a mechanism for selectivity in target gene activation by the tumor suppressor protein p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204457

Increased apoptosis induction by 121F mutant p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204457

Mammalian p53 can function as a transcription factor in yeast

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204457

Reactivation of mutant p53 through interaction of a C-terminal peptide with the core domain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204457

Tumor surveillance via the ARF-p53 pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204457

Structural aspects of the p53 protein in relation to gene evolution: a second look.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204457

A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204457

One mechanism for cell type-specific regulation of the bax promoter by the tumor suppressor p53 is dictated by the p53 response element

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204457

Discrimination of DNA Binding Sites by Mutant p53 Proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204457

PA26, a novel target of the p53 tumor suppressor and member of the GADD family of DNA damage and growth arrest inducible genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204457

Failure of wild-type p53 gene therapy in human cancer cells expressing a mutant p53 protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204457

Evolutionary conservation and somatic mutation hotspot maps of p53: correlation with p53 protein structural and functional features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204457

Increased and altered DNA binding of human p53 by S and G2/M but not Gl cyclin-dependent kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204457

Hot-spot mutants of p53 core domain evince characteristic local structural changes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204457

MCG10, a novel p53 target gene that encodes a KH domain RNA-binding protein, is capable of inducing apoptosis and cell cycle arrest in G(2)-M

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204457

Prognostic significance ofp53 mutation in breast cancer: Frequent detection of non-missense mutations by yeast functional assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204457

7 January 2021

BTG gene expression in the p53-dependent and -independent cellular response to DNA damage

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204457

7 January 2021

Identification of human p53 mutations with differential effects on the bax and p21 promoters using functional assays in yeast

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204457

7 January 2021

Pharmacological rescue of mutant p53 conformation and function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204457

7 January 2021

Mutation of conserved domain II alters the sequence specificity of DNA binding by the p53 protein.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204457

7 January 2021

Determining mutational fingerprints at the human p53 locus with a yeast functional assay: a new tool for molecular epidemiology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204457

7 January 2021

PCR-Based Random Mutagenesis Using Manganese and Reduced dNTP Concentration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204457

7 January 2021

New developments in the multi-site phosphorylation and integration of stress signalling at p53

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204457

7 January 2021

High frequency in esophageal cancers of p53 alterations inactivating the regulation of genes involved in cell cycle and apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204457

7 January 2021

Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204457

7 January 2021

Structure-based rescue of common tumor-derived p53 mutants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204457

7 January 2021

Adenovirus-mediated p53 growth inhibition of ovarian cancer cells is independent of endogenous p53 status

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204457

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1204457

1 reference

Dimensions Publication ID

25 November 2017

1037531092

0 references

1 reference